Assessing Caspase-Mediated Cleavage of Viral and Host Proteins in Virus-Infected Cells
JoVE Encyclopedia of Experiments
Immunology
0 views • 3:34 min • July 8th, 2025
Begin with virus-infected mammalian cells that produce multiple caspases, including caspase-3.
Add a growth medium to the control well and a caspase-3 inhibitor-supplemented medium to the test well.
In the control well, caspase-3 recognizes and degrades the viral nucleoproteins and host proteins essential for viral propagation.
In the test well, the inhibitor enters the cell, inhibiting caspase-3 activity and preventing protein degradation.
Dislodge cells from the plate. Add a lysing reagent and heat to induce cell lysis, releasing intracellular proteins.
Load both samples on an SDS-polyacrylamide gel and electrophorese to separate proteins based on size.
After electrophoresis, transfer the gel to a blotting membrane.
Treat the membrane with primary antibodies against viral nucleoproteins and host proteins.
Wash and overlay with fluorophore-conjugated secondary antibodies binding with primary antibodies, generating fluorescent bands.
The higher fluorescence in the test sample indicates reduced caspase-3 mediated viral and host protein cleavage compared to the control.
To begin, seed MDCK or A549 cells in a 12-well cell culture plate, incubate the cells overnight at 37 degrees Celsius under a 5% carbon dioxide atmosphere. On the next day, remove the old culture medium from the cells and wash the cells in each well twice with 1 milliliter of serum-free MEM.
Then infect the cells by adding 400 microliters of influenza A virus inoculum and place the plate for incubation for one hour. After incubation, remove the virus inoculum and wash the cells with MEM. Add 1 milliliter of serum-free MEM to each well, and incubate the cells as shown in the previous step.
After 24 hours, harvest the cells by scraping them with a 1-milliliter syringe plunger, and transfer them to a 1.5-milliliter tube. Centrifuge the tube at 12,000 g for two minutes at room temperature, and collect the supernatant. Wash the cell pellet with 250 microliters of phosphate-buffered saline and centrifuge. Remove the supernatant and add 100 microliters of cell lysis buffer. Mix by vortex.
Heat the tube at 98 degrees Celsius for 10 minutes to completely lyse the cells. Then, resolve equal amounts of protein from uninfected and infected samples by standard SDS polyacrylamide gel electrophoresis. After electrophoresis, transfer the protein gel to a nitrocellulose or PVDF membrane and perform western blotting. Compare the protein levels in the mock-treated and inhibitor-treated infected sample lanes.
Overview
This study investigates the role of caspase-3 in the degradation of viral nucleoproteins and host proteins in virus-infected mammalian cells. By utilizing a caspase-3 inhibitor, the research aims to elucidate the impact of caspase-3 activity on protein cleavage and viral propagation.
Key Study Components
Area of Science
- Cell biology
- Virology
- Protein analysis
Background
- Caspases are critical enzymes involved in apoptosis and cellular processes.
- Influenza A virus infection leads to the activation of caspases.
- Understanding caspase-3's role could provide insights into viral replication mechanisms.
- Western blotting is a key technique for analyzing protein levels.
Purpose of Study
- To determine the effect of caspase-3 on viral and host protein degradation.
- To assess the efficacy of a caspase-3 inhibitor in preventing protein cleavage.
- To compare protein levels in infected cells treated with and without the inhibitor.
Methods Used
- Infection of MDCK or A549 cells with influenza A virus.
- Use of a caspase-3 inhibitor to assess its impact on protein degradation.
- Cell lysis and protein extraction using a lysis buffer.
- Western blotting to analyze protein levels and cleavage.
Main Results
- Inhibition of caspase-3 resulted in reduced cleavage of viral nucleoproteins.
- Fluorescent bands indicated differences in protein levels between control and test samples.
- Higher fluorescence in test samples confirmed the effectiveness of the inhibitor.
Conclusions
- Caspase-3 plays a significant role in the degradation of proteins during viral infection.
- Inhibiting caspase-3 can prevent the cleavage of essential viral and host proteins.
- This study provides insights into potential therapeutic strategies against viral infections.
Frequently Asked Questions
Executive Industry Relevance
Caspase-mediated protein cleavage in virus-infected cells represents a critical mechanistic checkpoint for understanding host-pathogen interactions and target validation in antiviral discovery. Quantitative assessment of caspase activity and its inhibition informs predictive confidence in pathway modulation and supports risk-adjusted advancement of antiviral candidates. This workflow enables biopharma teams to de-risk early discovery decisions by clarifying the functional impact of caspase activity on both viral and host protein stability.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of caspase-driven protein degradation pathways during viral infection.
- Supports functional validation of caspase-3 as a mechanistic target for antiviral intervention.
- Provides quantitative evidence for pathway modulation using specific inhibitors.
- Facilitates triage of targets based on biological relevance and mechanistic clarity.
Screening & Assay Development
- Establishes a validated system for measuring caspase-mediated cleavage via western blotting.
- Delivers reproducible, quantitative outputs for inhibitor efficacy assessment.
- Supports standardization of assay conditions for downstream screening campaigns.
- Enables reliable evaluation of compound effects on protein stability in infected cells.
Translational & Preclinical Research
- Aligns mechanistic findings with disease-relevant viral infection models.
- Provides continuity from discovery-stage target validation to preclinical pathway interrogation.
- Informs risk-adjusted decisions for advancing caspase-targeting strategies.
- Supports translational biomarker development by quantifying protein cleavage events.
Pipeline & Workflow Integration
This method integrates into the early discovery and target validation stages, bridging mechanistic interrogation with assay development and preclinical evaluation in antiviral R&D pipelines.
- Discovery Biology: Quantifies caspase-dependent cleavage to clarify pathway roles in viral infection.
- Screening: Provides standardized, reproducible readouts for inhibitor testing.
- Analytics: Enables comparative analysis of protein levels across experimental conditions.
- Translational Research: Connects mechanistic insights to disease-relevant cellular models.
- Enterprise Reuse: Offers a reusable workflow for evaluating caspase activity in diverse viral contexts.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation and mechanistic de-risking.
- Operational Value: Delivers standardized, scalable, and reproducible assay outputs.
- Strategic Value: Supports informed go/no-go decisions and reduces late-stage biological risk.
- Portfolio Impact: Enables risk-adjusted prioritization of antiviral targets and candidates.
Implementation Considerations
- Requires expertise in cell culture, viral infection, and protein analysis.
- Needs access to western blotting instrumentation and analytical infrastructure.
- Demands cross-team standardization of assay protocols and controls.
- Adaptable to different cell lines and viral models with protocol optimization.
- Dependent on availability of specific inhibitors and validated antibodies.
Biopharma FAQs
Caspase-3 Activity in the Rat Amygdala Measured by Spectrofluorometry After Myocardial Infarction
Related Videos
0 Views
Evaluation of Caspase Activation to Assess Innate Immune Cell Death
Related Videos
0 Views
Measuring Caspase Activity Using a Fluorometric Assay or Flow Cytometry
Related Videos
0 Views
Assessment of the Activation of Multiple Caspases in Macrophages
Related Videos
0 Views
An Assay to Evaluate the Effect of Test Compounds on Viral Entry and Fusion in Host Cells
Related Videos
0 Views
Use of a Caspase Multiplexing Assay to Determine Apoptosis in a Hypothalamic Cell Model
Related Videos
0 Views
Purification of Viral DNA for the Identification of Associated Viral and Cellular Proteins
Related Videos
0 Views
Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors
Related Videos
0 Views
A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation
Related Videos
0 Views
Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods
Related Videos
0 Views
Last updated: 22 August 2026